Analyst target price targets were adjusted for multiple companies, including American Express, BioCryst Pharmaceuticals, and American Airlines Group.
2 reports, 1 independent
Updated Jul 9
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst target price targets were adjusted for multiple companies, including American Express, BioCryst Pharmaceuticals, and American Airlines Group.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
American Express
American multinational financial services corporation
-
Cantor Fitzgerald
American financial services company
- The event reports that Brooke Rollins serves as Trump's Agriculture Secretary and notes that Lutnick previously ran Cantor Fitzgerald.
- Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.
-
BioCryst Pharmaceuticals
American pharmaceutical company
Nothing else this week.
Related events
- Analyst firms issued price targets and ratings involving Benchmark, Booking Holdings, and Cantor Fitzgerald.
- Analyst firm raises price target on Ryman Hospitality Properties stock on May 27, 2026.
- Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.
- Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.
- Multiple financial institutions, including Goldman Sachs, JPMorgan Chase, and UBS, issued various target price changes on shares.